(Q40921755)

24 September 2017

1 reference

title

Desogestrel, norgestimate, and gestodene: the newer progestins (English)

1 reference

24 September 2017

B Kaplan

1

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

29

1 reference

24 September 2017

issue

7-8

1 reference

24 September 2017

page(s)

736-742

1 reference

The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Potency of progestogens in oral contraceptives--further delay of menses data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Combined oral contraceptives: acceptability and effective use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Pharmacokinetics of desogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Potency and pharmacokinetics of gestagens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Effects of desogestrel on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Contraceptive efficacy of a monophasic oral contraceptive containing desogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

A method for assessing the quality of a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Lipid metabolism effects with desogestrel-containing oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Characteristics of the new progestogens in combination oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Oral contraceptives. Are drug interactions of clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

Clinical and hormonal effects of two contraceptives: Correlation to serum concentrations of levonorgestrel and gestodene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502907-817

10.1177/106002809502907-817

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference